Stopped: The study stopped because the study period already ended
The goal of this clinical trial is to analyze the effect of N-Acetylcysteine administration towards blood oxidant level, transaminase enzyme, and bilirubin level in ALL children who undergo induction phase of chemotherapy. The main question it aims to answer is whether N-Acetylcysteine can decrease oxidative stress level and reduce hepatotoxicity complication. Participants will be evaluated for MDA level, transaminase enzymes and bilirubin level before, during, and after the chemotherapy. Participants will be given capsules containing 600mg of N-Acetylcysteine as adjunctive treatment during the 6 weeks induction phase of chemotherapy. Researchers will compare the lab results to the placebo group to see if there is any significant difference in the results.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
MDA (Malondialdehyde)
Timeframe: Change from Baseline Malondialdehyde level at 7 week
Aspartate aminotransferase
Timeframe: Change from Baseline Aspartate aminotransferase level at 7 week
Alanine transaminase
Timeframe: Change from Baseline Alanine transaminase level at 7 week
Bilirubin
Timeframe: Change from Baseline Bilirubin level at 7 week